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Abstract The number of new fungal pathogens is
increasing due to growing population of immunocom-
promised patients and advanced identification tech-
niques. Fereydounia khargensis is a yeast and was first
described in 2014 from environmental samples. As far
as we know, this is the first report of human infections
associated with F. khargensis. The yeasts were
isolated from blood of a HIV-positive patient and
pleural fluid of chronic renal failure patient. Ampli-
fication and sequencing of the internal transcribed
spacer and the large subunit regions confirmed the
identity of the isolates. Both isolates showed multi-
drug resistance to antifungal agents tested.
Keywords Fereydounia khargensis Urocystidales 
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Introduction
Fereydounia khargensis was first described by Nasr
et al. [1], isolated from plant remnants on the Kharg
Island in the Persian Gulf of Iran. Based on phyloge-
netic analysis of the large subunit (LSU) in the
ribosomal RNA (rRNA) gene, the organism is clus-
tered in the same order (Urocystidales) with a few
species of smut fungi, for example Ustacystis
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waldsteiniae, Mandkurella kalopanacis, Doassan-
siopsis deformans and Thecaphora seminis-convolvuli
[1]. F. khargensis represents a new lineage in the
Urocystidales, of the subphylum Ustilaginomycotina.
Members of Ustilaginomycotina are usually dimor-
phic, producing a saprobic haploid yeast phase and a
parasitic dikaryotic hyphal phase [2]. There are about
1500 species of subphylum Ustilaginomycotina [2, 3],
and they are found largely in temperate climate
countries rather than in tropical countries [4]. Estab-
lished as plant parasites, few species of Ustilagino-
mycotina had been reported to cause infection in
human, i.e. Pseudozyma antarctica, P. parantarctica,
P. thailandica and P. aphidis [5–7].
The identification of F. khargensis by conventional
phenotypic methods is almost impossible, due to
unfamiliar characteristics of the isolates. Therefore,
the identification was accomplished by amplification
and sequencing of the internal transcribed spacer (ITS)
and LSU regions in the rRNA gene. We report the first
two cases of F. khargensis isolated from the blood
sample of a human immunodeficiency virus (HIV)-
positive patient and the pleural fluid of a chronic renal
failure patient. In vitro susceptibility testing against
amphotericin B, caspofungin, anidulafungin, flucona-
zole, itraconazole and voriconazole was also carried
out on the yeast isolates.
Case Studies
Case 1
A 33-year-old HIV-positive patient was admitted to
Queen Elizabeth Hospital in Kota Kinabalu, Sabah,
Malaysia, due to developed episodes of fever associ-
ated with chills and rigours that persisted for 2 weeks.
The fever was high grade, ranging between 39 and
40 C, and was persistent in nature. There were no
other associated symptoms such as cough, shortness of
breath, chest pain, abdominal pain or diarrhoea. The
patient did not suffer from headache or visual distur-
bance. There was no loss of appetite; however, the
patient had weight loss. Apart from the high temper-
ature recorded, general physical examination was
unremarkable. Further investigation such as chest
X-ray did not revealed the cause of the fever. On
admission, his HIV viral load was 2.4 9 105 copies
with a CD4 count of 63 cells/mm3. However, the viral
load decreased to\20 copies after 5 days of highly
active antiretroviral therapy (HAART) and his CD4
count improved to 353 cells/mm3 9 days after the
initial reading. The patient was empirically started on
intravenous (IV) ceftriaxone 1 g three times/day, oral
co-trimoxazole 160 mg/800 mg daily and IV Tazocin
4.5 g every 8 h.
The blood culture that was performed on the day of
admission did not reveal any growth. It was repeated
on several occasions, positive on sixth day of hospi-
talisation after 48 h of incubation. The Gram stain of
the positive blood culture revealed yeast elements.
Following the blood culture finding, amphotericin B
was given with initial IV infusion of 1–5 mg/day
of amphotericin B, gradually increasing it to 0.4–0.6
mg/kg daily for 7 days. Treatment was switched to IV
itraconazole 200 mg twice daily for 2 days, followed
by 200 mg/day for 12 days as the patient did not
improve clinically after treatment with ampho-
tericin B. The patient’s clinical condition markedly
improved after 5 days following this new antifungal
regime.
Case 2
A 59-year-old male, with a known case of end-stage
renal failure on continuous ambulatory peritoneal
dialysis (CAPD), hypertension, diabetes mellitus and
hepatitis B carrier, was admitted to Sultanah Fatimah
Hospital in Muar, Johor, Malaysia, due to a dislodged
distal connector of Tenckhoff catheter after an alleged
fall in the toilet at home. There was no loss of
consciousness, but he had nausea and dizziness prior
to fall. After the event, the dislodged connector was
reconnected to the Tenckhoff catheter and used for
CAPD. There was no history of abdominal pain,
distention or fever.
On examination, the patient was conscious and
alert. The lungs were clear, and the abdomen was soft
and non-tender. Daily full examination and micro-
scopy examination (FEME) and cell count of the
peritoneal fluid (PF) presented clear and colourless,
with no white blood cell (WBC) seen until the fifth day
of the admission. On the fifth day, the FEME of the PF
revealed 30 WBC/ll, with 90 % polymorphs and
10 % lymphocytes. On the sixth day, the WBC count
of the PF increased to a significant level, i.e.
225 WBC/ll with 80 % polymorphs and 20 % lym-
phocytes indicative of an infection. It was sent for a
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culture in aerobic blood culture bottle. After 48 h
incubation, Gram stain exhibited a mixed growth of
Gram-negative, rod-shaped bacterium and yeast-like
cells. The Gram-negative bacteria were identified as
Pseudomonas fluorescens; however, the yeast-like
organism was unable to be identified using the ID 32C
yeast identification systems. No specimen was sent in
anaerobic blood culture bottle. A repeat PF culture
was sent in aerobic blood culture bottle on the 9 days
which grew solely a yeast-like organism with the same
characteristics as the fifth day. The PF was also sent
for culture in anaerobic blood culture bottle on the
eighth day and it grew coagulase-negative methicillin-
resistant Staphylococcus.
A dosage of 400 mg/day once a day of fluconazole
was started following the yeast growth from the PF.
The patient’s Tenckhoff catheter was removed imme-
diately and changed to a new one following the
positive PF culture. The clinical condition of the
patient improved after 10 days of the fluconazole
treatment and he was discharged well. On the subse-
quent follow-up 1 month later, his PF cell count was
reducing in trend. His PFWBC count was 75 WBC/ll
with 30 % polymorphs and 70 % lymphocytes.
Mycological Investigations
Both positive cultures grew yeast-like organisms on
Sabouraud’s dextrose agar (SDA) and were sent to the
Mycology Laboratory at the Institute for Medical
Research (IMR) for identification. Upon receival at the
laboratory, the yeast-like colonies were subcultured
onto new SDA plates and incubated at 35 C for
further tests. The isolates of Case 1 and Case 2 were
designated as strain UZ1799/14 and UZ1801/15,
respectively. Growths on both SDA plates represented
as cream coloured yeast-like colonies, dry and with
slightly wrinkled and fringed margins (Fig. 1a).
However, after 72 h of incubation, the colonies for
both strains started producing melanin-like pigmenta-
tion and it became even darker after 120 h of
incubation (Fig. 1b).
Lactophenol cotton blue (LPCB) smear of 48-h-old
isolates revealed short stalk reproduced by polar
budding of ellipsoidal and elongation of blastospore
(Fig. 2). Slide cultures were also carried out on corn
meal agar and incubated at room temperature (25 C)
for observation of hyphae production. After 72 h of
incubation, the slide cultures revealed production of
hyphae, pseudohyphae and blastospores (Fig. 3).
Assimilation tests were carried out by API 20C
AUX (bioMe´rieux, Marcy l’Etoile, France) and
VITEK 2 system (bioMe´rieux, Marcy l’Etoile, France)
following the manufacturer protocols. Both systems
misidentified the isolates, in which the API 20C and
VITEK 2 produced results as Cryptococcus neofor-
mans (98 % probability) and Cryptococcus laurentii
(89 % probability), respectively.
Identification by Molecular Methods
DNA extractions, amplifications by polymerase chain
reaction (PCR), PCR products purification and
sequencing methods were performed as previously
described [8]. The internal transcribed spacer (ITS)
and the large subunit (LSU) in rRNA gene regions
were amplified using universal primers ITS5/ITS4 and
NL1/NL4 as previously described by Scholch et al. [9]
and O’Donnell [10], respectively. NCBI BLAST
search (http://blast.ncbi.nlm.nih.gov/) was performed
for the ITS and LSU sequences from both isolates;
resulting in a 99.7 and 100.0 % matched to the refer-
ence strain, IBRC-M30116 (Table 1).
In Vitro Susceptibility Test
In vitro susceptibility test was carried out using the
E testmethod. Themethodwas performed according to
the manufacturer’s protocols (AB Biodisk 2007). The
antifungals tested were amphotericin B, caspofungin,
anidulafungin, fluconazole, itraconazole and voricona-
zole. The minimum inhibitory concentration (MIC) of
the antifungals was determined at 24 and 48 h
(Table 2) and the interpretation of the MIC followed
the Clinical and Laboratory Standards Institute (CLSI)
guidelines (2008). In vitro susceptibility pattern
showed that fluconazole, itraconazole and voricona-
zole have good activity against the yeast, although the
MIC readings of the azole agents for strain UZ1801/15
were higher than UZ1799/14. On the other hand, both
isolates showed resistant pattern to amphotericin B,
caspofungin and anidulafungin with MIC reading of
[32.000 lg ml-1 for amphotericin B, caspofungin
and anidulafungin; except the MIC for caspofungin of
the strain UZ1801/15 which was 4.000 lg ml-1.
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Discussion
We report to our knowledge, the first two cases of
fungal infection associated with F. khargensis in
immunocompromised patients. The isolates produced
melanin-like pigmentation on SDA and were accu-
rately identified based on amplification of the ITS and
LSU regions. In vitro susceptibility test of the isolates
showed multi-drug resistance against amphotericin B,
anidulafungin and caspofungin, but sensitive to azole
agents tested.
Fereydounia khargensis characterises a new lin-
eage in the Urocystidales of the subphylum Ustilagi-
nomycotina. In this case report, the organism exists as
Fig. 1 Yeast-like colonies of strain UZ1799/14 on SDA plate after incubation at 48 h (a) and the melanin-like pigment was clearly
seen after 120 h incubation (b)
Fig. 2 LPCB stain of F. khargensis at 9100 magnification
showing bipolar budding of blastospores
Fig. 3 Production of branching hyphae (a); pseudohyphae and blastospores (b) on corn meal agar of the slide cultures,
magnification 940
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yeast phase on normal isolation media, i.e. Sabour-
aud’s dextrose agar (SDA), and as hyphal phase on
corn meal agar. It grew well at 35 C and the growth
rate is quite fast (within 24 h). The initial colony
characteristics are more similar to Trichosporon spp.
rather than Candida spp., i.e. cream coloured, dry and
slightly wrinkled. However, the production of mela-
nin-like pigmentation after 3 days incubation on SDA
is a unique characteristic of the isolate. However, the
same species strain IBRC-M30116 do not produce
melanin-like pigmentation after 7 days incubation on
yeast peptone glucose (YPG), malt extract agar
(MEA), malt yeast 40 % sucrose agar (M40Y) and
dichloran 18 % glycerol (DG18) at 28 C [1].
Conventional identification methods did not allow
the accurate identification of F. khargensis. The
microscopic characteristics of F. khargensis from
LPCB staining and slide culture were unfamiliar to us.
In addition, the commercial yeast identification sys-
tems (API 20C and VITEK 2) were also unable to
identify the isolate due to limited databases of the
systems. Therefore, diagnostic laboratories in which
the yeast identification systems depend on the colony
morphology and commercial system may not be able
to accurately identify this new and uncommon yeast.
Fortunately with the molecular methods available, the
identification was made possible. The two regions in
the rRNA gene, i.e. ITS and LSU, are variable and
have been used for identification of many uncommon
yeast spp. [7, 11–13].
In this case report, the low CD4 count of Case 1
patient and the complicated medical conditions of
Case 2 patient predisposed the patients to immunod-
eficiency, thus susceptible to the infections of F.
khargensis. The interactions between host immune
status and pathogen have been reported to be the
crucial determinants of the type of invasive fungal
infection among patients at risk of it [14]. For
example, there are many ascomycetous yeast species
from the Candida genus that can become pathogens
when the host’s resistance to infection is locally or
systemically impaired. In an immunocompromised
host, translocation from the gastrointestinal tract and
intravascular catheters are the two main portals of
entry for disseminated yeast infection [14, 15].
Antifungal treatment remains a challenge for
patient with unusual yeast infection, since to date
only a few antifungal agents are currently available.
The situation is compounded when most available
antifungal drugs are usually associated with serious
Table 1 Sources, accession numbers and nucleotides similarity between the three strains of F. khargensis













UZ1799/14 Human blood Malaysia 99.7 KP326581 100.0 KT362712 This report
UZ1801/15 Human pleural fluid Malaysia KU212883 KU321687 This report
IBRC-M30116 Plant remnants Iran KJ490642 KJ490641 [1]




S sensitive, R resistant
MIC (lg ml-1)
Strain UZ1799/14 Strain UZ1801/15
24 h 48 h 24 h 48 h
Amphotericin B [32.000 [32.000 (R) 16.000 [32.000 (R)
Caspofungin [32.000 [32.000 (R) 2.000 4.000 (R)
Anidulafungin [32.000 [32.000 (R) [32.000 [32.000 (R)
Fluconazole 0.500 2.000 (S) 3.000 8.000 (S)
Itraconazole 0.047 0.094 (S) 0.094 0.125 (S)
Voriconazole 0.008 0.032 (S) 1.000 2.000 (S)
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side effects and the fact that some organisms have
developed resistance against antifungals [16]. In this
case report, findings of in vitro susceptibility test were
parallel with in vivo. For instance, patient 1 was
initially treated with amphotericin B; however, his
clinical condition was not improved until it was
switched to itraconazole, parallel with our in vitro
study that showed the isolate to be resistant to
amphotericin B, but sensitive to itraconazole. In
patient 2, the clinical condition was improved after
1 week of fluconazole treatment. A similar finding
was observed in vitro, in which the isolate was
sensitive to azole agents tested (fluconazole, itracona-
zole and voriconazole).
With the development in identificationmethods and
the increasing population of patients who are immun-
odeficient or undergoing long-term immunosuppres-
sion treatment, the number of new and uncommon
yeasts that cause diseases is growing. Thus, it has
become a challenge to accurately identify these
species. The growing number of resistant yeast species
has also simultaneously increased, thus posing a
challenge in antifungal treatment and patient manage-
ment. Pathogenicity, mode of transmission and resis-
tance mechanism of F. khargensis remain unanswered.
Further investigation of F. khargensis is necessary to
accomplish the gaps.
Conclusion
This study reported F. khargensis causing septicaemia
in immunocompromised patients. Commercially avail-
able systems failed to identify the yeasts. However,with
the advancement of technology, the isolates were
correctly identified by PCR-sequencing, i.e. by ampli-
fication of the ITS and LSU region of the rRNA gene.
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